Reports for APOTEX INC
Company Name
APOTEX INC
Shortage reports
Actual shortage:
220 (7%)
Anticipated shortage:
0 (0%)
Avoided shortage:
10 (0%)
Resolved:
3124 (93%)
3354
Discontinuation Reports
To be discontinued:
25 (7%)
Discontinued:
342 (93%)
Reversed:
0 (0%)
367
146 (4%)
70 (29%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-VARENICLINE | 1MG | TABLET | Resolved | 2020-04-13 | 2020-05-19 | 111957 |
| APO-VARENICLINE | 0.5MG 1MG | KIT TABLET | Resolved | 2020-04-13 | 2020-05-19 | 111963 |
| APO-VARENICLINE | 0.5MG | TABLET | Resolved | 2020-05-20 | 2020-06-15 | 115407 |
| APO-VARENICLINE | 0.5MG 1MG | KIT TABLET | Resolved | 2020-06-24 | 2020-08-10 | 118784 |
| APO-VARENICLINE | 1MG | TABLET | Resolved | 2020-07-23 | 2020-08-10 | 120988 |
| APO-VARENICLINE | 1MG | TABLET | Resolved | 2023-11-06 | 2023-12-01 | 209366 |
| APO-VARENICLINE | 1MG | TABLET | Resolved | 2024-04-19 | 2024-07-05 | 225764 |
| APO-VARENICLINE | 1MG | TABLET | Resolved | 2023-04-21 | 2023-04-27 | 190014 |
| APO-VARENICLINE | 1MG | TABLET | Resolved | 2023-05-12 | 2023-06-02 | 192364 |
| APO-VARENICLINE | 0.5MG | TABLET | Resolved | 2023-05-26 | 2023-06-02 | 193227 |
| APO-VARENICLINE | 1MG | TABLET | Resolved | 2025-01-09 | 2025-04-04 | 247385 |
| APO-VARENICLINE | 1MG | TABLET | Resolved | 2020-09-02 | 2020-09-14 | 123586 |
| APO-VARENICLINE | 0.5MG 1MG | KIT TABLET | Resolved | 2020-09-02 | 2020-09-14 | 123589 |
| APO-VARENICLINE | 0.5MG 1MG | KIT TABLET | Resolved | 2020-10-14 | 2020-10-30 | 126320 |
| APO-VARENICLINE | 0.5MG | TABLET | Resolved | 2020-12-18 | 2021-04-26 | 130416 |
| APO-VARENICLINE | 0.5MG 1MG | KIT TABLET | Resolved | 2021-02-05 | 2021-03-01 | 133394 |
| APO-VARENICLINE | 1MG | TABLET | Resolved | 2021-02-19 | 2021-02-26 | 134445 |
| APO-VARENICLINE | 1MG | TABLET | Resolved | 2021-05-07 | 2025-01-31 | 138992 |
| APO-VARENICLINE | 0.5MG | TABLET | Resolved | 2021-07-05 | 2021-08-30 | 141857 |
| APO-VARENICLINE | 1MG 0.5MG | TABLET KIT | Resolved | 2021-11-29 | 2025-01-02 | 150175 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-BISACODYL | 5MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-09-07 | 2018-09-15 | 60288 |
| APO-BOSENTAN | 62.5MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71339 |
| APO-BOSENTAN | 125.0MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71342 |
| APO-BOSENTAN | 125.0MG | TABLET | Discontinued | 2018-09-07 | 2018-10-31 | 60291 |
| APO-BRIMONIDINE | 0.2% | SOLUTION | Discontinued | 2018-09-07 | 2018-12-28 | 60301 |
| APO-BRIMONIDINE | 0.2% | SOLUTION | Discontinued | 2020-11-16 | 2020-11-16 | 128438 |
| APO-BRIMONIDINE | 0.2% | SOLUTION | To be discontinued | 2018-09-07 | 2018-09-07 | 60294 |
| APO-BROMAZEPAM - TAB 1.5MG | 1.5MG | TABLET | To be discontinued | 2018-09-07 | 2018-09-07 | 60304 |
| APO-BROMAZEPAM - TAB 3MG | 3MG | TABLET | Discontinued | 2018-09-07 | 2019-06-12 | 60307 |
| APO-BROMAZEPAM - TAB 6MG | 6MG | TABLET | Discontinued | 2018-09-07 | 2018-10-19 | 60310 |
| APO-CANDESARTAN | 16MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60313 |
| APO-CANDESARTAN | 16MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60316 |
| APO-CANDESARTAN | 8MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60325 |
| APO-CANDESARTAN | 8MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60322 |
| APO-CANDESARTAN | 4MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60319 |
| APO-CANDESARTAN | 32MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60328 |
| APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60331 |
| APO-CANDESARTAN/HCTZ | 25MG 32MG | TABLET | Discontinued | 2018-02-26 | 2018-05-03 | 41011 |
| APO-CANDESARTAN/HCTZ | 12.5MG 32MG | TABLET | Discontinued | 2018-02-26 | 2018-02-26 | 41020 |
| APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-02-26 | 2018-02-26 | 41047 |